Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Peng Peng

2PUBLICATIONS

17CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jul 15, 2026

Tinengotinib (TT-00420) inhibits tumor growth and overcomes multidrug resistance in gastrointestinal cancers.

|Oct 12, 2022

Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer.

Peng Peng, Xiaoyan Qiang, Guoyu Li

Pageof 1

Frequent Collaborators

2 joint publications

Xiaoyan Qiang

1 joint publications

Guoyu Li

1 joint publications

Lin Li

1 joint publications

Shumao Ni

1 joint publications

Qi Yu

1 joint publications

Laura Sourd

1 joint publications

Elisabetta Marangoni

1 joint publications

Chao Hu

1 joint publications

Dong Wang

1 joint publications

Di Wu

Frequent Collaborators

2 joint publications

Xiaoyan Qiang

1 joint publications

Guoyu Li

1 joint publications

Lin Li

1 joint publications

Shumao Ni